Drug for #COVID19 now: #REMDESIVIR : made by Gilead
Gilead holds the PATENT and that means that it has a monopoly on the drug in the US. It's the only company that can manufacture it until 2037, at which point a generic version could be possible.
Gilead holds the PATENT and that means that it has a monopoly on the drug in the US. It's the only company that can manufacture it until 2037, at which point a generic version could be possible.
2. Remdesivir: article from end of April "...looked at the chemical synthesis of the drug and concluded that a 10-day course for one person would cost $9, allowing for 20% losses during formulation, plus the cost of the vials, a profit margin, and tax." https://arstechnica.com/science/2020/04/who-owns-remdesivir-how-much-can-they-make-and-how-much-does-it-cost/
3. NIH has also invested millions in potential treatments for COVID-19, like remdesivir, a drug made by Gilead Sciences that has been authorized by the Food and Drug Administration for emergency use for hospitalized patients with severe disease. https://www.middletownpress.com/news/coronavirus/article/Lawmakers-seek-to-curb-price-of-coronavirus-drugs-15358138.php
4. On January 21, it was reported that China’s Wuhan Institute of Virology of the Chinese Academy of Sciences filed a patent for commercial use of remdesivir in China. https://www.trialsitenews.com/wuhan-institute-of-virology-china-sought-to-patent-gileads-remdesivir/
5. ...Gilead will announce its pricing plans for remdesivir soon and start selling it commercially in the second half of the year... The analysts estimate the price will be $5,000 per course in the U.S., $4,000 in Europe and $2,000 elsewhere. https://www.fiercepharma.com/pharma/remdesivir-stockpiling-could-help-push-covid-drug-into-profitable-territory-for-gilead
6. Remdesivir’s contribution pushed SVB Leerink’s estimate for Gilead’s total sales in 2021 up 28% to
$30 billion!!!!
$30 billion!!!!
7. Medical wisdom:
Hydroxychloroquine (HCQ)
VS.
Money:
Remdesivir, an intravenous (IV) experimental antiviral medicine https://aapsonline.org/a-tale-of-two-drugs-money-vs-medical-wisdom/
Hydroxychloroquine (HCQ)
VS.
Money:
Remdesivir, an intravenous (IV) experimental antiviral medicine https://aapsonline.org/a-tale-of-two-drugs-money-vs-medical-wisdom/
@threadreaderapp please unroll. Thanq÷
Gilead history:
Chairman of Gilead Sciences Donald Rumsfeld & Board Member, Former U.S. Secretary of State, George Schultz profited heavily from a $1.5 billion stockpiling by the U.S. government on Tamiflu leading up to the 2009 H1N1 “swine flu” outbreak https://greatgameindia.com/gilead-sciences-the-coronavirus-vaccine-manufacturer-accused-of-bioterrorism/
Chairman of Gilead Sciences Donald Rumsfeld & Board Member, Former U.S. Secretary of State, George Schultz profited heavily from a $1.5 billion stockpiling by the U.S. government on Tamiflu leading up to the 2009 H1N1 “swine flu” outbreak https://greatgameindia.com/gilead-sciences-the-coronavirus-vaccine-manufacturer-accused-of-bioterrorism/